SEC Form 4 · accession 0001179110-18-005850
RIGEL PHARMACEUTICALS INC · RIGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anne-Marie Duliege
Officer — EVP & Chief Medical Officer
Period of report
Apr 20, 2018
Accepted (ET)
Apr 24, 2018 · 9:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001034842
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Apr 20, 2018 | S | 5,000 | $4.11 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2018.
- F2The Reporting Person purchased these shares on December 29, 2017 under the Employee Stock Purchase Plan.